Spire Healthcare Group (LON:SPI) Shares Pass Above 50-Day Moving Average – Should You Sell?

Spire Healthcare Group plc (LON:SPI)’s stock price passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 226.83 and traded as high as GBX 237. Spire Healthcare Group shares last traded at GBX 237, with a volume of 807,006 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 245 target price on shares of Spire Healthcare Group in a research note on Friday, May 15th. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat, Spire Healthcare Group presently has a consensus rating of “Buy” and a consensus price target of GBX 245.

Spire Healthcare Group Stock Up 2.1%

The company has a market cap of £965.44 million, a P/E ratio of 60.25, a PEG ratio of 1.06 and a beta of 0.93. The stock’s 50-day moving average price is GBX 227.11 and its 200-day moving average price is GBX 200.66. The company has a current ratio of 0.63, a quick ratio of 0.73 and a debt-to-equity ratio of 177.14.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.